» Articles » PMID: 28552575

Structural Studies of HHARI/UbcH7∼Ub Reveal Unique E2∼Ub Conformational Restriction by RBR RING1

Overview
Journal Structure
Publisher Cell Press
Date 2017 May 30
PMID 28552575
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

RING-between-RING (RBR) E3s contain RING1 domains that are structurally similar yet mechanistically distinct from canonical RING domains. Both types of E3 bind E2∼ubiquitin (E2∼Ub) via their RINGs but canonical RING E3s promote closed E2∼Ub conformations required for direct Ub transfer from the E2 to substrate, while RBR RING1s promote open E2∼Ub to favor Ub transfer to the E3 active site. This different RING/E2∼Ub conformation determines its direct target, which for canonical RING E3s is typically a substrate or substrate-linked Ub, but is the E3 active-site cysteine in the case of RBR-type E3s. Here we show that a short extension of HHARI RING1, namely Zn-loop II, not present in any RING E3s, acts as a steric wedge to disrupt closed E2∼Ub, providing a structural explanation for the distinctive RING1-dependent conformational restriction mechanism utilized by RBR E3s.

Citing Articles

Structural basis for the pathogenicity of parkin catalytic domain mutants.

Wagner J, Sauve V, Saran A, Gehring K J Biol Chem. 2024; 301(1):108051.

PMID: 39631693 PMC: 11742612. DOI: 10.1016/j.jbc.2024.108051.


Chemical Tools for Probing the Ub/Ubl Conjugation Cascades.

Kochanczyk T, Fishman M, Lima C Chembiochem. 2024; 26(1):e202400659.

PMID: 39313481 PMC: 11727022. DOI: 10.1002/cbic.202400659.


Capturing the catalytic intermediates of parkin ubiquitination.

Connelly E, Rintala-Dempsey A, Gundogdu M, Freeman E, Koszela J, Aguirre J Proc Natl Acad Sci U S A. 2024; 121(32):e2403114121.

PMID: 39078678 PMC: 11317638. DOI: 10.1073/pnas.2403114121.


A de novo ARIH2 gene mutation was detected in a patient with autism spectrum disorders and intellectual disability.

Vinci M, Treccarichi S, Galati Rando R, Musumeci A, Todaro V, Federico C Sci Rep. 2024; 14(1):15848.

PMID: 38982159 PMC: 11233510. DOI: 10.1038/s41598-024-66475-2.


Parkin-mediated ubiquitination inhibits BAK apoptotic activity by blocking its canonical hydrophobic groove.

Cheng P, Hou Y, Bian M, Fang X, Liu Y, Rao Y Commun Biol. 2023; 6(1):1260.

PMID: 38087033 PMC: 10716173. DOI: 10.1038/s42003-023-05650-z.


References
1.
Emsley P, Lohkamp B, Scott W, Cowtan K . Features and development of Coot. Acta Crystallogr D Biol Crystallogr. 2010; 66(Pt 4):486-501. PMC: 2852313. DOI: 10.1107/S0907444910007493. View

2.
Duda D, Olszewski J, Schuermann J, Kurinov I, Miller D, Nourse A . Structure of HHARI, a RING-IBR-RING ubiquitin ligase: autoinhibition of an Ariadne-family E3 and insights into ligation mechanism. Structure. 2013; 21(6):1030-41. PMC: 3747818. DOI: 10.1016/j.str.2013.04.019. View

3.
Delaglio F, Grzesiek S, Vuister G, Zhu G, Pfeifer J, Bax A . NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR. 1995; 6(3):277-93. DOI: 10.1007/BF00197809. View

4.
Kelsall I, Duda D, Olszewski J, Hofmann K, Knebel A, Langevin F . TRIAD1 and HHARI bind to and are activated by distinct neddylated Cullin-RING ligase complexes. EMBO J. 2013; 32(21):2848-60. PMC: 3817463. DOI: 10.1038/emboj.2013.209. View

5.
Pruneda J, Stoll K, Bolton L, Brzovic P, Klevit R . Ubiquitin in motion: structural studies of the ubiquitin-conjugating enzyme∼ubiquitin conjugate. Biochemistry. 2011; 50(10):1624-33. PMC: 3056393. DOI: 10.1021/bi101913m. View